BTC Health Limited (BTC.AX)
AUD 0.05
(0.0%)
AUD 0.05
(0.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 | -1.03 Million AUD | 0.0% |
| 2023 | - AUD | 1417.13% |
| 2022 | - AUD | 63.33% |
| 2021 | - AUD | -9.23% |
| 2020 | - AUD | -55.21% |
| 2019 | - AUD | -39.7% |
| 2018 | - AUD | 207.45% |
| 2017 | - AUD | 125.25% |
| 2016 | - AUD | 10.81% |
| 2015 | - AUD | 31.07% |
| 2014 | - AUD | -38.27% |
| 2013 | - AUD | 8.47% |
| 2012 | - AUD | -42.27% |
| 2011 | - AUD | -51.19% |
| 2010 | - AUD | -74.99% |
| 2009 | - AUD | 258.11% |
| 2008 | - AUD | -17.49% |
| 2007 | - AUD | -5.76% |
| 2006 | - AUD | -7.71% |
| 2005 | - AUD | -37.86% |
| 2004 | - AUD | 111.98% |
| 2003 | 1.04 Million AUD | 12.88% |
| 2002 | 924 Thousand AUD | -2.01% |
| 2001 | 943 Thousand AUD | 0.0% |
| 2000 | - AUD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q4 | -76.26 AUD | 0.0% |
| 2024 Q2 | 321.26 Thousand AUD | 0.0% |
| 2024 FY | 1.03 Million AUD | -89.8% |
| 2023 FY | 10.18 Million AUD | 1417.13% |
| 2023 Q4 | 9.91 Million AUD | 0.0% |
| 2023 Q2 | 263.78 Thousand AUD | 0.0% |
| 2022 FY | 671.07 Thousand AUD | 63.33% |
| 2022 Q4 | 243.84 Thousand AUD | 0.0% |
| 2022 Q2 | 427.23 Thousand AUD | 0.0% |
| 2021 FY | 410.87 Thousand AUD | -9.23% |
| 2021 Q4 | 212.99 Thousand AUD | 0.0% |
| 2021 Q2 | 197.88 Thousand AUD | 0.0% |
| 2020 Q4 | 174.74 Thousand AUD | 0.0% |
| 2020 FY | 452.63 Thousand AUD | -55.21% |
| 2020 Q2 | 402.89 Thousand AUD | 0.0% |
| 2019 Q4 | 584.7 Thousand AUD | 0.0% |
| 2019 FY | 1.01 Million AUD | -39.7% |
| 2019 Q2 | 350.8 Thousand AUD | 0.0% |
| 2018 FY | 1.67 Million AUD | 207.45% |
| 2018 Q2 | 1.2 Million AUD | 0.0% |
| 2018 Q4 | 474.43 Thousand AUD | 0.0% |
| 2017 Q2 | 206.82 Thousand AUD | 0.0% |
| 2017 FY | 545.02 Thousand AUD | 125.25% |
| 2017 Q4 | 338.19 Thousand AUD | 0.0% |
| 2016 Q4 | 801.41 Thousand AUD | 0.0% |
| 2016 Q2 | 140.55 Thousand AUD | 0.0% |
| 2016 FY | 241.96 Thousand AUD | 10.81% |
| 2015 FY | 218.36 Thousand AUD | 31.07% |
| 2015 Q4 | 391.98 Thousand AUD | 0.0% |
| 2015 Q2 | 126.38 Thousand AUD | 0.0% |
| 2014 Q4 | 74.91 Thousand AUD | 0.0% |
| 2014 FY | 166.6 Thousand AUD | -38.27% |
| 2014 Q2 | 1.82 Million AUD | 0.0% |
| 2013 Q4 | 73.51 Thousand AUD | 43.86% |
| 2013 Q2 | 465.94 Thousand AUD | 792.59% |
| 2013 Q3 | 51.09 Thousand AUD | -89.03% |
| 2013 Q1 | 52.2 Thousand AUD | 0.0% |
| 2013 FY | 269.89 Thousand AUD | 8.47% |
| 2012 Q4 | 52.2 Thousand AUD | 0.0% |
| 2012 Q2 | 52.2 Thousand AUD | -46.32% |
| 2012 Q1 | 97.25 Thousand AUD | 0.0% |
| 2012 FY | 248.81 Thousand AUD | -42.27% |
| 2012 Q3 | 52.2 Thousand AUD | 0.0% |
| 2011 Q3 | 97.25 Thousand AUD | 0.0% |
| 2011 FY | 431 Thousand AUD | -51.19% |
| 2011 Q4 | 97.25 Thousand AUD | 0.0% |
| 2011 Q2 | 97.25 Thousand AUD | -52.79% |
| 2011 Q1 | 206 Thousand AUD | 0.0% |
| 2010 Q2 | 206 Thousand AUD | 1.6% |
| 2010 Q3 | 206 Thousand AUD | 0.0% |
| 2010 Q4 | 206 Thousand AUD | 0.0% |
| 2010 FY | 883 Thousand AUD | -74.99% |
| 2010 Q1 | 202.75 Thousand AUD | 0.0% |
| 2009 Q4 | 202.75 Thousand AUD | 0.0% |
| 2009 Q1 | 246.5 Thousand AUD | 0.0% |
| 2009 Q2 | 202.75 Thousand AUD | -17.75% |
| 2009 Q3 | 202.75 Thousand AUD | 0.0% |
| 2009 FY | 3.53 Million AUD | 258.11% |
| 2008 Q1 | 298.75 Thousand AUD | 0.0% |
| 2008 Q4 | 246.5 Thousand AUD | 0.0% |
| 2008 Q3 | 246.5 Thousand AUD | 0.0% |
| 2008 FY | 986 Thousand AUD | -17.49% |
| 2008 Q2 | 246.5 Thousand AUD | -17.49% |
| 2007 Q4 | 298.75 Thousand AUD | 0.0% |
| 2007 Q3 | 298.75 Thousand AUD | 0.0% |
| 2007 Q2 | 298.75 Thousand AUD | -5.76% |
| 2007 Q1 | 317 Thousand AUD | 0.0% |
| 2007 FY | 1.19 Million AUD | -5.76% |
| 2006 Q2 | 317 Thousand AUD | -7.71% |
| 2006 Q3 | 317 Thousand AUD | 0.0% |
| 2006 FY | 1.26 Million AUD | -7.71% |
| 2006 Q4 | 317 Thousand AUD | 0.0% |
| 2006 Q1 | 343.5 Thousand AUD | 0.0% |
| 2005 Q1 | 315.5 Thousand AUD | 0.0% |
| 2005 Q4 | 343.5 Thousand AUD | 0.0% |
| 2005 FY | 1.37 Million AUD | -37.86% |
| 2005 Q3 | 343.5 Thousand AUD | 0.0% |
| 2005 Q2 | 343.5 Thousand AUD | 8.87% |
| 2004 Q1 | 195.5 Thousand AUD | 0.0% |
| 2004 Q2 | 315.5 Thousand AUD | 61.38% |
| 2004 FY | 2.21 Million AUD | 111.98% |
| 2004 Q4 | 315.5 Thousand AUD | 0.0% |
| 2004 Q3 | 315.5 Thousand AUD | 0.0% |
| 2003 Q3 | 195.5 Thousand AUD | 0.0% |
| 2003 FY | 1.04 Million AUD | 12.88% |
| 2003 Q1 | 203.52 Thousand AUD | 0.0% |
| 2003 Q2 | 195.5 Thousand AUD | -3.94% |
| 2003 Q4 | 195.5 Thousand AUD | 0.0% |
| 2002 Q1 | 235.75 Thousand AUD | 0.0% |
| 2002 Q4 | 203.52 Thousand AUD | 0.0% |
| 2002 FY | 924 Thousand AUD | -2.01% |
| 2002 Q2 | 203.52 Thousand AUD | -13.67% |
| 2002 Q3 | 203.52 Thousand AUD | 0.0% |
| 2001 Q4 | 235.75 Thousand AUD | 0.0% |
| 2001 Q2 | 235.75 Thousand AUD | 0.0% |
| 2001 Q1 | - AUD | 0.0% |
| 2001 FY | 943 Thousand AUD | 0.0% |
| 2001 Q3 | 235.75 Thousand AUD | 0.0% |
| 2000 Q2 | - AUD | 0.0% |
| 2000 Q4 | - AUD | 0.0% |
| 2000 Q3 | - AUD | 0.0% |
| 2000 FY | - AUD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| AdAlta Limited | 6.76 Million AUD | 115.347% |
| Biome Australia Limited | 7.91 Million AUD | 113.132% |
| Radiopharm Theranostics Limited | 299.22 Thousand AUD | 447.202% |
| Biotron Limited | 5.11 Million AUD | 120.329% |
| Acrux Limited | 8.55 Million AUD | 112.151% |
| Alterity Therapeutics Limited | 23.4 Million AUD | 104.439% |
| Botanix Pharmaceuticals Limited | 601.82 Thousand AUD | 272.631% |
| Chimeric Therapeutics Limited | 19.76 Million AUD | 105.256% |
| CSL Limited | 7.56 Billion AUD | 100.014% |
| Clarity Pharmaceuticals Ltd | 56.3 Million AUD | 101.845% |
| Clinuvel Pharmaceuticals Limited | 31.29 Million AUD | 103.32% |
| Immutep Limited | 42.87 Million AUD | 102.423% |
| Memphasys Limited | 3.67 Million AUD | 128.244% |
| Neuren Pharmaceuticals Limited | 32.69 Million AUD | 103.177% |
| Noxopharm Limited | 7 Million AUD | 114.841% |
| Prescient Therapeutics Limited | 10.89 Million AUD | 109.533% |
| Race Oncology Limited | 14.77 Million AUD | 107.034% |
| Starpharma Holdings Limited | 22.81 Million AUD | 104.554% |
| Tissue Repair Ltd | 6.66 Million AUD | 115.584% |
| EZZ Life Science Holdings Limited | 39.57 Million AUD | 102.625% |
| Anatara Lifesciences Ltd | 710.21 Thousand AUD | 246.283% |
| Bio-Gene Technology Limited | 2.76 Million AUD | 137.628% |
| Zelira Therapeutics Limited | 5.94 Million AUD | 117.465% |
| Patrys Limited | 4.93 Million AUD | 121.059% |
| Orthocell Limited | 15.36 Million AUD | 106.76% |
| Imugene Limited | 135.09 Million AUD | 100.769% |
| PYC Therapeutics Limited | 60.91 Million AUD | 101.705% |
| Proteomics International Laboratories Limited | 892.14 Thousand AUD | 216.453% |
| Cynata Therapeutics Limited | 11.12 Million AUD | 109.34% |
| Arovella Therapeutics Limited | 10.78 Million AUD | 109.633% |
| Nanollose Limited | 12.5 Thousand AUD | 8410.751% |
| Invex Therapeutics Ltd | 3.34 Million AUD | 131.051% |
| NeuroScientific Biopharmaceuticals Limited | 1.96 Million AUD | 152.866% |
| Amplia Therapeutics Limited | 8.43 Million AUD | 112.316% |
| Island Pharmaceuticals Limited | 4.12 Million AUD | 125.184% |
| Nyrada Inc. | 4.55 Million AUD | 122.808% |
| Telix Pharmaceuticals Limited | 269.26 Million AUD | 100.386% |
| Dimerix Limited | 25.64 Million AUD | 104.051% |
| PharmAust Limited | 6.65 Million AUD | 115.607% |
| Hexima Limited | 1 Million AUD | 202.992% |
| AnteoTech Limited | 12.18 Million AUD | 108.525% |
| Paradigm Biopharmaceuticals Limited | 65.1 Million AUD | 101.596% |
| Recce Pharmaceuticals Ltd | 21.68 Million AUD | 104.791% |
| Avecho Biotechnology Limited | 4.54 Million AUD | 122.857% |
| Actinogen Medical Limited | 22.77 Million AUD | 104.563% |
| Immuron Limited | 9.13 Million AUD | 111.369% |
| Argenica Therapeutics Limited | 8.26 Million AUD | 112.564% |